Your session is about to expire
← Back to Search
Estrogen Therapy for Type 1 Diabetes
Study Summary
This trial will investigate if estrogen contributes to heart problems in premenopausal women with diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a man or a woman who has not gone through menopause.You have been using hormonal birth control in the last 3 months.My diabetes is not under control (HbA1c over 9%).I am taking or have taken medications that block estrogen.I have complications from diabetes.I have been diagnosed with polycystic ovarian syndrome.Irregular or infrequent menstrual periods.I have type 1 diabetes and need insulin.My menstrual cycles are regular, lasting 25-35 days for the last 3 cycles.Presence of protein in the urine.Your Anti-Mullerian Hormone (AMH) level cannot be detected during screening.I am not taking any medications that directly affect blood vessel function.My blood pressure is not controlled, even with medication.I have been diagnosed with liver, heart, or kidney disease.
- Group 1: Women with type 1 diabetes
- Group 2: Men with type 1 diabetes
- Group 3: Healthy control women
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently enrolled in this clinical trial?
"Yes, according to the clinicaltrials.gov page, this research project is actively seeking participants. First posted on April 17th 2018 and last modified on July 18th 2022; 198 individuals need to be enrolled across two locations."
Does this scientific experiment offer access to those in their octogenarian years?
"Patients aged between 18 and 40 years are invited to participate in this medical trial."
Is enrollment still ongoing for this clinical experiment?
"Affirmative. Clinicaltrials.gov data affirms that this medical trial, initially posted on April 17th 2018 and most recently updated 18 July 2022 is actively recruiting for 198 patients at 2 sites."
What are the criteria for eligibility to partake in this clinical experiment?
"This study is admitting a cohort of 198 individuals aged between 18 and 40 who have diabetes or an autoimmune condition. The patient population must include both male and premenopausal females of all racial backgrounds."
Share this study with friends
Copy Link
Messenger